DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.03
-0.48 (-6.39%)
Apr 16, 2026, 4:00 PM EDT - Market closed

DarioHealth Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-41.71-42.75-59.43-62.19-76.76
Depreciation & Amortization
3.147.434.994.724.46
Stock-Based Compensation
9.3715.819.716.9824.97
Other Adjustments
1.66-15.080.772.64-0.29
Change in Receivables
2.661.683.26-5.11-0.35
Changes in Inventories
0.440.312.89-1.73-2.23
Changes in Accounts Payable
-0.12-0.5-1.19-2.791.08
Changes in Accrued Expenses
-0.78-3.48-0.26-1.31-0.87
Changes in Unearned Revenue
-0.87-0.16-0.320.13-0.16
Changes in Other Operating Activities
0.29-1.81-0.790.83-0.26
Operating Cash Flow
-25.94-38.56-30.38-47.85-50.41
Capital Expenditures
-0.14-0.14-0.58-0.44-0.26
Purchases of Intangible Assets
----0.13-
Purchases of Investments
-4.2--5--
Proceeds from Sale of Investments
--5.03--
Payments for Business Acquisitions
--8.8---7.47
Other Investing Activities
-----0.4
Investing Cash Flow
-4.34-8.93-0.55-0.57-8.13
Long-Term Debt Issued
31.7-29.623.79-
Long-Term Debt Repaid
-31.52--27.83--
Net Long-Term Debt Issued (Repaid)
0.19-1.7723.79-
Issuance of Common Stock
17.37-1.6138.2965.77
Repurchase of Common Stock
----0.13-
Net Common Stock Issued (Repurchased)
17.37-1.6138.1565.77
Issuance of Preferred Stock
6.7538.5314.87--
Net Preferred Stock Issued (Repurchased)
6.7538.5314.87--
Financing Cash Flow
24.3138.5318.2561.9465.77
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.01-0.07---
Net Cash Flow
-5.97-8.97-12.6713.527.22
Free Cash Flow
-26.08-38.7-30.96-48.29-50.67
FCF Margin
-116.66%-143.12%-152.14%-174.60%-247.01%
Free Cash Flow Per Share
-6.55-15.78-21.83-40.86-61.08
Levered Free Cash Flow
-59.6-39.33-57.01-40.65-77
Unlevered Free Cash Flow
-34.8-53.69-51.51-57.41-74.76
Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q